LLY stock gains as BofA raises price target to $1,251, citing obesity drug momentum
LLY stock gains as BofA raises price target to $1,251, citing obesity drug momentum eciks.org
LLY stock gains as BofA raises price target to $1,251, citing obesity drug momentum eciks.org
Summary aggregated from eciks.org's public RSS feed. The full reporting belongs to eciks.org — please read it on their site.